Neurologic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Live Coverage of PAINWeek 2014

Exclusive access to live, onsite coverage of up-to-date evidence-based scientific findings in pain management.

Parkinson's Meds May Spur Compulsive Behaviors

Medications commonly used to treat Parkinson's disease may raise the risk of impulse control disorders such as compulsive gambling, compulsive shopping, and/or hypersexuality.

No Link Between Vaccines, Multiple Sclerosis

There is no link between vaccines and increased risk of multiple sclerosis or other acquired central nervous system demyelinating syndromes, according to a recent study.

Can Cocoa Improve Memory Loss?

A lab-created cocoa drink appears to improve normal age-related memory loss, according to a small new study.

Herpes Simplex Virus and Alzheimer's Disease

Herpes simplex virus (HSV) infection might increase the risk of Alzheimer's disease, two studies by Swedish researchers suggest.

Mediterranean, DASH Diets Slow Cognitive Decline? ...

Can adhering to the Mediterranean or DASH (Dietary Approach to Stop Hypertension) diets help slow cognitive decline in elderly patients?

Concussions After Age 65 and Dementia

A mild concussion after age 65 may increase the risk of developing dementia.

More Safety, Efficacy Data for Aubagio

Genzyme announced that the Food and Drug Administration (FDA) has approved the inclusion of clinical data from the TOWER and TOPIC studies of Aubagio (teriflunomide).

News

Does Prenatal Exposure to Epilepsy Drugs Actually Lower IQ in Offspring?

Prenatal exposure to sodium valproate (VPA) is associated with a reduction in offspring IQ, according to a review published in The Cochrane Library.

Sleep Issues Tied to Alzheimer's, Dementia Risk in Elderly Men

Insufficient sleep has been linked to brain health in animal and human studies, and new research has found an association between sleep disturbance and risk of dementia and Alzheimer's disease in older men

NBI-98854 Designated Breakthrough Therapy for Tardive Dyskinesia

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for NBI-98854 (Neurocrine Biosciences) for tardive dyskinesia.

TWi Approved for Generic Aricept

TWi Pharmaceuticals announced it has received final approval from the Food and Drug Administration (FDA) for Donepezil HCl Tablets, the generic version of Eisai's Aricept.

FEATURES

Does Prenatal Exposure to Epilepsy Drugs Actually Lower IQ in Offspring?

Does Prenatal Exposure to Epilepsy Drugs Actually Lower IQ in Offspring?

Prenatal exposure to sodium valproate (VPA) is associated with a reduction in offspring IQ, according to a review published in The Cochrane Library.

Sleep Issues Tied to Alzheimer's, Dementia Risk in Elderly Men

Insufficient sleep has been linked to brain health in animal and human studies, and new research has found an association between sleep disturbance and risk of dementia and Alzheimer's disease in older men

NBI-98854 Designated Breakthrough Therapy for Tardive Dyskinesia

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for NBI-98854 (Neurocrine Biosciences) for tardive dyskinesia.

Featured courses from mycme

Comprehensive Review of Electrodiagnostic Medicine and Neuromuscular DisordersExternal web site

Led by Program Directors Anthony A. Amato, MD, and William S. David, MD, PhD, authoritative ...

CME 31.50 Credits

UCLA Review of Clinical NeurologyExternal web site

Led by Course Chair Alon Avidan, MD, MPH, the authoritative faculty of The UCLA Review ...

CME 23.00 Credits

Clinicians Explore EV-D68, Paralysis LinkExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters